Practitioner-Grade Nutrition

Blog

Why vitamin D3 and K2 are packaged together

Vitamin D3 and vitamin K2 are packaged together because they run two halves of the same job. D3 governs how much calcium you absorb; K2 activates the proteins that decide where that calcium ends up. Take more of one without enough of the other and you push on half of a system. That is the whole logic of the pairing — not marketing, just the biochemistry of two fat-soluble vitamins that were separated by the supplement aisle and not by the body.

Key takeaways

D3 raises calcium absorption — in a controlled crossover study, absorption was 65% higher at a serum 25(OH)D of 86.5 nmol/L than at 50 nmol/L (Heaney 2003).

K2 activates osteocalcin and matrix Gla-protein, the proteins that bind calcium into bone and keep it out of soft tissue — and 10–40% of them circulate inactive in healthy adults (Theuwissen 2012).

The K2 form matters as much as the dose: after identical 420 µg doses, MK-4 was undetectable in serum while MK-7 was still measurable at 48 hours (Sato 2012).

Three years of 180 µg/day MK-7 slowed the age-related decline in bone mineral density and bone strength in a 244-person randomized trial (Knapen 2013).

What D3 actually does with calcium

Vitamin D3’s best-understood job is absorption. Without adequate 25-hydroxyvitamin D — the storage form your blood test measures — a meaningful share of the calcium you swallow passes straight through.

The classic demonstration comes from Robert Heaney’s group at Creighton University. In a randomized crossover experiment, the same 500 mg oral calcium load was absorbed 65% better when participants’ serum 25(OH)D averaged 86.5 nmol/L than when it averaged 50 nmol/L — both values inside the lab reference range (Heaney et al., J Am Coll Nutr, 2003). Being “in range” and absorbing well are not the same thing.

Data: Heaney et al., Journal of the American College of Nutrition, 2003 (PMID 12672710).

So D3 opens the gate. The question the label rarely answers is what happens to the calcium once it is inside.

What K2 does that D3 cannot

Two of the body’s calcium-handling proteins only work after vitamin K activates them, in a step called carboxylation:

Osteocalcin, made by bone-building cells, binds calcium into the bone matrix — but only in its carboxylated form.
Matrix Gla-protein (MGP) is the body’s principal inhibitor of unwanted soft-tissue calcification. Uncarboxylated, it is a bystander.

Here is the part worth reading twice: in healthy adults, 10–40% of circulating osteocalcin and MGP is uncarboxylated — produced, present, and inactive for want of vitamin K. In a randomized dose-response trial, MK-7 at nutritionally realistic doses increased the carboxylation of both proteins (Theuwissen et al., Br J Nutr, 2012). Vitamin D actually increases the production of these K-dependent proteins, which is the mechanistic heart of the pairing: more D means more proteins waiting on K (van Ballegooijen et al., Int J Endocrinol, 2017).

That is why the two appear in one capsule. D3 without K2 raises the calcium supply and the inactive-protein pool at the same time. Together, the system runs the way the physiology textbooks draw it.

MK-7 vs MK-4: the form question, again

If you read our piece on magnesium forms, you already know the house obsession: the form on the label changes what the body receives. Vitamin K2 has its own version of this. Two forms dominate the supplement market — MK-4 (short side-chain) and MK-7 (long side-chain) — and they behave very differently after you swallow them.

In a head-to-head study in healthy women, a single 420 µg dose of MK-4 was not detectable in serum at any time point. The identical dose of MK-7 was well absorbed and still measurable 48 hours later (Sato et al., Nutr J, 2012). Earlier pharmacokinetic work comparing MK-7 with vitamin K1 found the same signature: similar peak, but a far longer half-life, letting MK-7 accumulate to 7–8× higher steady-state levels with daily intake and drive more complete osteocalcin carboxylation (Schurgers et al., Blood, 2007).

Data: Sato et al., Nutrition Journal, 2012 (PMID 23140417).

MK-7’s long residence time is not a trivial convenience. A once-daily dose holds serum levels steady around the clock, which is precisely what you want for a vitamin whose job is continuous protein activation.

What the long-term trial showed

The most demanding test of low-dose MK-7 to date is a three-year, double-blind, randomized trial in 244 healthy postmenopausal women taking 180 µg/day. MK-7 improved vitamin K status, slowed the age-related decline in bone mineral content and density at the lumbar spine and femoral neck, and favorably affected bone strength indices (Knapen et al., Osteoporos Int, 2013). The carboxylation markers moved first; the structural measures followed over years, which is how bone works — slowly, in the direction the activated proteins push it.

Note the honest print: this was 180 µg daily for three years in one population. It is support for the mechanism, not a promise, and bone responds to training, protein, and total diet at least as much as to any capsule.

How to read a D3 + K2 label

Applying the house method — read the panel, not the front — four things tell you whether a combination product is serious:

Check	What to look for	Why
D3 form	Cholecalciferol, dose in mcg and IU	D3 is the form made in skin; 25 mcg = 1,000 IU
K2 form	MK-7 named explicitly	“Vitamin K2” alone can hide MK-4, which a single daily dose may not sustain (Sato 2012)
K2 dose	90–180 µg range	The range where carboxylation measurably improves (Theuwissen 2012; Knapen 2013)
Fat-solubility handled	Take with a meal; absorption enhancers declared	Both vitamins are fat-soluble

Our own Vitamin K2 + D3 is the worked example: one veggie capsule carries 125 mcg (5,000 IU) D3 as cholecalciferol with 100 mcg K2 explicitly as MK-7, plus 210 mg calcium and 5 mg BioPerine®, with every batch third-party tested and its certificate of analysis published. The label states the forms because the forms are the argument.

Frequently asked questions

Can I take D3 without K2?

You can — D3 on its own reliably raises 25(OH)D and calcium absorption. The case for pairing is mechanistic: higher vitamin D status increases production of the K-dependent proteins, so demand for vitamin K rises with your D intake (van Ballegooijen 2017). The pairing simply keeps both halves of the calcium system supplied.

Is MK-7 better than MK-4?

At typical once-daily supplement doses, MK-7 has the pharmacokinetic advantage: measurable in serum for days rather than hours, building 7–8× higher steady-state levels (Schurgers 2007; Sato 2012). MK-4 has its own research history at much higher, multi-dose regimens — a different product category than a daily capsule.

How much K2 do studies use?

Carboxylation of osteocalcin and MGP improved at doses around 90–180 µg/day of MK-7 (Theuwissen 2012), and the three-year bone trial used 180 µg/day (Knapen 2013). Most quality combination products sit in that window.

Why is calcium in the capsule too?

A modest calcium co-dose (ours is 210 mg, 15% DV) gives the absorption machinery a substrate without displacing dietary calcium — most people should still get the bulk of their calcium from food.

The bottom line

D3 decides how much calcium comes in. K2 — as MK-7, at a dose the carboxylation studies actually used — decides whether the proteins that place that calcium are switched on. One capsule, two switches, both halves of the system covered. That is why they are packaged together.

References

Heaney RP, et al. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22(2):142-6. PMID 12672710 · DOI
Theuwissen E, et al. Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status. Br J Nutr. 2012;108(9):1652-7. PMID 22289649 · DOI
Sato T, Schurgers LJ, Uenishi K. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women. Nutr J. 2012;11:93. PMID 23140417 · DOI
Schurgers LJ, et al. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109(8):3279-83. PMID 17158229 · DOI
Knapen MHJ, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499-507. PMID 23525894 · DOI
van Ballegooijen AJ, et al. The synergistic interplay between vitamins D and K for bone health: a narrative review. Int J Endocrinol. 2017;2017:7454376. PMID 29138634 · DOI

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Citations describe published research on nutrient physiology; individual results vary, and supplements complement — never replace — a varied diet.

September 7, 2026

Magnesium glycinate vs citrate vs oxide: what the form actually changes

Magnesium glycinate, citrate and oxide are not interchangeable. They differ in how much elemental magnesium each carries, how well that magnesium is absorbed, and how the gut tolerates what is left behind. Oxide carries the most magnesium by weight and delivers the least of it. Glycinate carries the least and is the gentlest. Citrate sits between the two and draws water into the bowel, which is why it appears in laxative preparations as well as supplements.

The form is not a detail. It is most of what separates two bottles that both say “Magnesium 400 mg” on the front.

Key takeaways

Magnesium oxide carries ~60% elemental magnesium but has a fractional absorption of about 4% in healthy adults (Firoz & Graber 2001).

In a 60-day randomized trial, citrate and amino-acid chelate outperformed oxide on every absorption marker — oxide was no different from placebo (Walker 2003).

Glycinate is absorbed in part as an intact dipeptide, riding the amino-acid transport pathway rather than competing with mineral absorption alone (Schuette 1994).

The only comparable number on any label is elemental magnesium — the figure the %DV is calculated from.

The three common forms, compared

Form	Elemental magnesium by weight	Bound to	Typical GI effect
Oxide	~60%	Oxygen	Poorly absorbed; the unabsorbed fraction is osmotic
Citrate	~16%	Citric acid	Moderately absorbed; osmotic at higher doses
Glycinate	~14% pure · ~11% buffered blends	Glycine (an amino acid)	Chelated; generally the best tolerated

Read that table twice, because it inverts the intuition. The form carrying the most magnesium by weight is the one that delivers the least. Magnesium oxide is roughly 60% elemental magnesium — far more than glycinate’s 14% — but it is poorly soluble, so much of it is never absorbed. What is not absorbed stays in the bowel and pulls water in behind it. That is a laxative mechanism, and it is why magnesium oxide has a long history in that role. Measured directly, oxide’s fractional absorption came to roughly 4% in healthy volunteers, against significantly higher and mutually equivalent absorption from chloride, lactate and aspartate salts (Firoz & Graber, Magnes Res, 2001).

Elemental yield is stoichiometric; absorption data: Firoz & Graber 2001 (PMID 11794633); Walker 2003 (PMID 14596323).

What “chelated” actually means

A chelate is a mineral bound to an organic molecule — here, magnesium bound to the amino acid glycine. The binding matters because the body has well-developed machinery for absorbing amino acids, and a chelated mineral can travel on it rather than relying on mineral absorption alone. This is not hand-waving: isotope-labelled magnesium diglycinate is absorbed in part as an intact dipeptide, and in the subjects with the most impaired mineral absorption it doubled uptake versus oxide (23.5% vs 11.8%) while being better tolerated by every participant (Schuette et al., JPEN, 1994).

The trade-off is arithmetic. Glycine is heavy relative to magnesium, so a chelated compound is mostly glycine by weight — pure magnesium bisglycinate is only about 14% elemental magnesium, and commercial glycinate materials (often buffered blends) run closer to 11%. Our own three-capsule serving is a worked example: 2,500 mg of magnesium glycinate yielding 275 mg of actual magnesium. Both numbers are true, and a label that prints only the larger one is telling you almost nothing.

Elemental magnesium is the only number worth comparing

This is where most label reading goes wrong. Two products can both claim magnesium and mean entirely different quantities:

“Magnesium Glycinate 500 mg” — the compound weight. The elemental magnesium is roughly 55 mg.
“Magnesium (as magnesium glycinate) 100 mg” — the elemental weight, stated properly.

The second is the honest construction, and it is what the Supplement Facts panel is designed to show: the nutrient first, the source in parentheses, the elemental amount, then the percent Daily Value. The %DV is the giveaway — it can only be calculated from elemental magnesium, so a panel showing a %DV is showing you the real number whether it means to or not.

If a front label states a large milligram figure and the Supplement Facts panel states a much smaller one, neither is lying. The front is quoting compound weight and the panel is quoting elemental. Compare panels, never front labels.

So which form

The head-to-head evidence is unusually clean. In a 60-day randomized, double-blind trial at a matched 300 mg elemental dose, both organic forms — citrate and amino-acid chelate — beat oxide on urinary, serum and salivary absorption markers, and oxide was indistinguishable from placebo (Walker et al., Magnes Res, 2003). Within the organic forms it depends on what you are optimising for:

Glycinate — when tolerability matters and you intend to take it daily over a long period.
Citrate — when cost per milligram of elemental magnesium matters more than GI comfort.
Oxide — rarely the right choice for repletion, and priced accordingly.

Blends muddy this further. A product listing three magnesium forms without stating the elemental contribution of each has told you the marketing story and withheld the arithmetic.

How to check any magnesium product in thirty seconds

Ignore the front of the bottle entirely.
Find Magnesium on the Supplement Facts panel and read the milligrams next to it. That is elemental.
Read the form in parentheses beneath it.
Check the serving size — a large number is sometimes three capsules, not one.
Divide by cost per serving if you are comparing products.

Our Magnesium Glycinate states both figures on the label: 275 mg of elemental magnesium from 2,500 mg of magnesium glycinate, per three-capsule serving. Printing both is the point — one number without the other is not a comparison anyone can make.

Frequently asked questions

Are “glycinate” and “bisglycinate” the same thing?

Functionally, yes — bisglycinate is the precise name (two glycine molecules per magnesium), glycinate the common one. The label distinction that actually matters is whether the material is a pure chelate (~14% elemental) or a buffered blend cut with oxide (~11%); the Supplement Facts panel’s elemental figure settles it.

Why does oxide dominate store shelves?

Density and cost. At ~60% elemental yield, oxide packs a big label number into a small cheap capsule. The absorption data is the part the front label leaves out.

Is citrate ever the better pick?

Yes — when cost per absorbed milligram is the priority and the osmotic effect is acceptable or even wanted. It absorbs well (Walker 2003); its trade-off is the bowel, not the bloodstream.

What does “compound weight” mean on a label?

The weight of the whole molecule — magnesium plus whatever it is bound to. “Magnesium glycinate 2,500 mg” is compound weight; the magnesium inside is 275 mg. The %DV can only be computed from the elemental figure, which is why the panel is the honest place to read.

The same form-first logic runs through the rest of the line — see why D3 and K2 are packaged together for the vitamin-K version of this argument, and the certificate of analysis library for the batch testing behind every label claim.

References

Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res. 2001;14(4):257-62. PMID 11794633
Walker AF, et al. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003;16(3):183-91. PMID 14596323
Schuette SA, Lashner BA, Janghorbani M. Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. JPEN J Parenter Enteral Nutr. 1994;18(5):430-5. PMID 7815675 · DOI

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

September 7, 2026